induction cisplatin

DRUG2 trials

Sponsors

Radiation Therapy Oncology Group, Wei Jiang

Conditions

Bladder CancerNasopharyngeal Carcinoma

Phase 2

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

CompletedNCT00777491

Radiation Therapy Oncology GroupBladder Cancer

Start: 2008-12-31End: 2022-05-20Updated: 2022-06-15

Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma

RecruitingNCT05097209

Wei JiangNasopharyngeal Carcinoma

Start: 2022-04-06End: 2026-04-06Target: 200Updated: 2023-03-23

Related Papers

Selective bladder preservation with twice-daily radiation plus 5-flourouracil/cisplatin (FCT) or daily radiation plus gemcitabine (GD) for patients with muscle invasive bladder cancer: Primary results of NRG/RTOG 0712—A randomized phase 2 multicenter trial.

Journal of Clinical Oncology2018-02-20